Background: Venom sac extract of yellow jackets Vespula vulgaris was toxic in mice when injected intraperitoneally but not toxic when injected subcutaneously. Necropsy showed the toxicity to be an inflammatory response. Methods: Venom peptide and protein fractions were tested to identify the inflammatory components. The active components were tested to establish whether they might function as adjuvant for venom protein-specific antibody response. Results: Venom toxicity required the synergistic action of two venom components, a mast cell degranulating peptide mastoparan and phospholipase A1. Both components stimulated prostaglandin E2 release from murine peritoneal cells and macrophages. Mastoparan showed a weak activity to enhance IgE and IgG1 responses to a yellow jacket venom protein Ves v 5 in BALB/c mice. It was not possible to assess the adjuvant activity of phospholipase A1 because of its suppression of Ves v 5-specific response. Melittin, a mast cell degranulating peptide from bee venom, was inactive as an adjuvant for Ves v 5-specific response. Conclusion: Yellow jacket venom contains two inflammatory components, mastoparan and phospholipase A1. Our findings suggest that mastoparan can function as a weak adjuvant for TH2 cell-associated antibody response.

1.
Habermann E: Bee and wasp venoms. Science 1972;177:314–322.
2.
King TP, Spangfort MD: Structure and biology of stinging insect venom allergens. Int Arch Allergy Immunol 2000;123:99–106.
3.
Fitch CD, Hoffman DR, Schmidt M: Cloning of a paper wasp venom serine protease allergen. J Allergy Clin Immunol 2001;107:S221.
4.
Hirai Y, Yasuhara T, Yoshida H, Nakajima T, Fujino M, Kitada C: A new mast cell degranulating peptide ‘Mastoparan’ in the venom of Vespula lewisii. Chem Pharm Bull (Tokyo) 1979;27:1942–1944.
5.
Argiolas A, Pisano JJ: Isolation and characterization of two new peptides, mastoparan C and crabolin, from the venom of the European hornet, Vespa crabo. J Biol Chem 1983;259:10106–10111.
6.
Nakajima T: Biochemistry of vespid venom; in Tu AT (ed): Handbook of Natural Toxins. New York, Dekker, 1984, vol 2, pp 109–133.
7.
Schulze U, Schrader KD, Chen R, Grotjahn L, Koenig W: A new mast cell degranulating peptide from the wasp. Z Naturforsch 1987;42b:897–902.
8.
Duvdevani P, Ishay JS, Schejter A: Mastoparan induces hypothermia in mice. Experientia 1990;47:460–462.
9.
Ho CH, Hwang LL: Structure and biological activities of a new mastoparan isolated from the venom of the hornet Vespa basalis. Biochem J 1991;274:453–456.
10.
Ho CL, Lin YL, Chen WC, Yu HM, Wang KT, Hwang LL, et al: Immunogenicity of mastoparan B, a cationic tetradecapeptide isolated from the hornet (Vespa basalis) venom, and its structural requirements. Toxicon 1995;33:1443–1451.
11.
Kind LS, Ramaika C, Allaway E: Antigenic, adjuvant and permeability enhancing properties of melittin in mice. Allergy 1981;36:155–160.
12.
King TP, Kochoumian L, Joslyn A: Melittin-specific monoclonal and polyclonal IgE and IgG1 antibodies from mice. J Immunol 1984;133:2668–2673.
13.
King TP, Sobotka AK, Kochoumian L, Lichtenstein LM: Allergens of honeybee venom. Arch Biochem Biophys 1976;172:661–671.
14.
King TP, Lu G, Gonzalez M, Qian NF, Soldatova L: Yellow jacket venom allergens, hyaluronidase and phospholipase: Sequence similarity and antigenic cross reactivity with their hornet and wasp homologs and possible implications for clinical allergy. J Allergy Clin Immunol 1996;98:588–600.
15.
Reynolds LJ, Hughes LL, Dennis EA: Analysis of human synovial fluid phospholipase A2 on short chain phosphatidylcholine-mixed micelles: Development of a spectrophotometric assay suitable for a microtiter plate reader. Anal Biochem 1992;204:190–197.
16.
Ding AH, Nathan CF, Stuehr DJ: Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. J Immunol 1988;141:2407–2412.
17.
King TP, Jim SY, Monsalve RI, Kagey-Sobotka A, Lichtenstein LM, Spangfort MD: Recombinant allergens with reduced allergenicity but retaining immunogenicity of the natural allergens: Hybrids of yellow jacket and paper wasp venom allergen antigen 5s. J Immunol 2001;166:6057–6065.
18.
Bobrow MN, Shaughnessy KJ, Litt GJ: Catalyzed reporter deposition, a novel method of signal amplification. II. Application to membrane immunoassays. J Immunol Methods 1991;137:103–112.
19.
Hirano T, Yamankawa N, Miyajima H, Maeda K, Takai S, Ueda A, Taniguchi O, Hashimoto H, Hirose S, Okumura K, Ovary Z: An improved method for the detection of IgE antibody of defined specificity by ELISA using rat monoclonal anti-IgE anibody. J Immunol Methods 1989;119:145–150.
20.
Susser E, Desvarieux M, Wittkowski KM: Reporting sexual risk behavior for HIV: A practical risk index and a method for improving risk indices. Am J Public Health 1998;88:671–674.
21.
Wittkowski KM: Friedman-type statistics and consistent multiple comparisons for unbalanced designs. J Am Stat Assoc 1988;83:1163–1170.
22.
Agriolas A, Pisano JJ: Facilitation of phospholipase A2 activity by mastoparans, a new class of mast cell degranulating peptides from wasp venom. J Biol Chem 1983;258:13697–13702.
23.
Chu RS, Targoni OS, Krieg AM, Lehmann PV, Harding CV: CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity. J Exp Med 1997;186:1623–1631.
24.
Higashijima T, Wakamatus K, Takemitsu M, Fujino M, Nakajima T, Miyazawa T: Conformational change of mastoparan from wasp venom on binding with phospholipid membrane. FEBS Lett 1983;152:227–230.
25.
Whiles JA, Brasseur R, Glover KJ, Melacini G, Komives EA, Vold RR: Orientation and effects of mastoparan X on phospholipid bicelles. Biophys J 2001;80:280–293.
26.
Wu TM, Chou TC, Ding YA, Li ML: Stimulation of TNF-alpha, IL1-beta and nitrite release from mouse cultured spleen cells and lavaged peritoneal cells by mastoparan M. Immunol Cell Biol 1999;77:476–482.
27.
Nakahata N, Imata K, Okawa T, Watanabe Y, Ishimoto H, Ono T, et al: Mastoparan elicits prostaglandin E2 generation and inhibits inositol phosphate accumulation via different mechanisms in rabbit astrocytes. Biochim Biophys Acta 1996;1310:60–66.
28.
Okano Y, Takai H, Tohmatsu T, Nakashima S, Kuoda Y, Saito K, Nozawa Y: A wasp venom mastoparan-induced polyphosphoinositide breakdown in rat peritoneal mast cells. FEBS Lett 1985;188:363–366.
29.
Mizuno K, Nakahata N, Ohizumi Y: Mastoparan-induced phosphatidylcholine hydrolysis by phospholipase D activation in human astrocytoma cells. Br J Pharmacol 1995;116:2090–2096.
30.
Mizuno K, Nakahata N, Ohizumi Y: Characterization of mastoparan-induced histamine release RBL-2H3 cells. Toxicon 1998;36:447–456.
31.
Higashijima T, Burnier J, Ross EM: Regulation of Gi and Go by mastoparan, related amphiphilic peptides and hydrophobic amines. J Biol Chem 1990;265:14176–14186.
32.
Ribardo DA, Crowe SE, Kuhl KR, Peterson JW, Chopra AK: Prostaglandin levels in stimulated macrophages are controlled by phospholipase A2-activating protein and by activation of phospholipase C and D. J Biol Chem 2001;276:5467–5475.
33.
Harris SG, Padilla J, Koumas L, Ray D, Phipps RP: Prostaglandins as modulators of immunity. Trends Immunol 2002;23:144–150.
34.
Dudler T, Machado DC, Kolbe L, Annand RR, Rhodes N, Gelb MH, Koelsch E, Suter M, Helm BA: A link between catalytic activity, IgE-independent mast cell activation, and allergenicity of bee venom phospholipase A2. J Immunol 1995;155:2605–2613.
35.
Arps V, Sudowe S, Kölsch E: Antigen dose-dependent differences in IgE antibody production are not due to polarization towards Th1 and Th2 cell subsets. Eur J Immunol 1998;28:681–686.
36.
Levine BB, Vaz NM: Effect of combinations of inbred strain, antigen and antigen dose on immune responsiveness and reagin production in the mouse. A potential mouse model for immune aspects of human atopic allergy. Int Arch Allergy Appl Immun 1970;39:156–171.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.